RVTY:NYE-Revvity Inc. (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 115.41

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.64M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-07 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

N/A

USD 192.25B
IQV IQVIA Holdings Inc

N/A

USD 43.52B
A Agilent Technologies Inc

N/A

USD 39.45B
LH Laboratory Corporation of Amer..

N/A

USD 18.80B
DGX Quest Diagnostics Incorporated

N/A

USD 17.18B
QGEN Qiagen NV

N/A

USD 10.30B
CRL Charles River Laboratories

N/A

USD 9.70B
VNRX Volitionrx Ltd

N/A

USD 0.06B
ENZ Enzo Biochem Inc

N/A

USD 0.06B
MTD Mettler-Toledo International I..

N/A

N/A

ETFs Containing RVTY

FLWR:SW 14.15 % 0.00 %

N/A

N/A
XMLH:XETRA L&G Healthcare Breakthrou.. 1.78 % 0.00 %

N/A

USD 0.07B
XMLH:F Legal & General Ucits Etf.. 1.78 % 0.00 %

N/A

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 1.78 % 0.00 %

N/A

USD 0.07B
EDGE-U:CA Evolve Innovation Index F.. 1.49 % 0.00 %

N/A

N/A
EWSP:SW iShares S&P 500 Equal Wei.. 0.23 % 0.00 %

N/A

USD 2.77B
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

N/A

CAD 0.27B
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.58% 69% C- 55% F
Dividend Return 0.19% 29% F 3% F
Total Return 5.77% 69% C- 46% F
Trailing 12 Months  
Capital Gain 8.03% 46% F 47% F
Dividend Return 0.26% 29% F 3% F
Total Return 8.29% 46% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.08% 23% F 31% F
Dividend Return -1.06% 23% F 20% F
Total Return 0.02% 14% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 3.66% 100% F 94% A
Risk Adjusted Return -28.87% 23% F 11% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector